CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention
| Autor: | Arsalan Salari, Vahid Nikseresht, Negar Moghadam, Mahboobeh Gholipour, Maryam Shakiba, Fardin Mirbolouk, Mohammad Jaafar Mirbolouk, Nozar Sotoudeh, Jalal Kheyrkhah, Mani Moayeri Far |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment 030204 cardiovascular system & hematology No-reflow STEMI 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Diseases of the circulatory (Cardiovascular) system 030212 general & internal medicine cardiovascular diseases Primary PCI business.industry Percutaneous coronary intervention Atrial fibrillation Odds ratio medicine.disease Confidence interval RC666-701 Conventional PCI No reflow phenomenon CHA2DS2–VASc score Cardiology cardiovascular system Original Article CHA2DS2-VASc Score Cardiology and Cardiovascular Medicine business TIMI |
| Zdroj: | Journal of Cardiovascular and Thoracic Research Journal of Cardiovascular and Thoracic Research, Vol 10, Iss 1, Pp 46-52 (2018) |
| ISSN: | 2008-5117 |
| Popis: | Introduction: No-reflow is one of the major complications of primary PCI in patients with acute ST elevation myocardial infarction. This phenomenon is associated with adverse outcomes in these patients. In the current study, we evaluated the effectiveness of CHA2DS2-VASc score in predicting no-reflow phenomenon. CHA2DS2-VASc score is a risk stratification method to estimate the risk of thromboembolism in patients with atrial fibrillation. Methods: In total, 396 patients with ST elevation myocardial infarction who had undergone primary PCI were evaluated in our study. Based on post interventional TIMI flow rate results, the patients were divided into two groups: control group (294 patients) and no-reflow group (102 patients). The CHA2DS2-VASc score was calculated for each participant. Multivariate regression analysis was performed to determine the predictive value of this score. Results: Our findings showed that CHA2DS2-VASc score can predict no-reflow independently (odds ratio: 3.06, 95%, confidence interval: 2.23-4.21, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|